v3.26.1
Goodwill and Intangible Assets, Net
12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net

8. Goodwill and Intangible Assets, Net

 

Goodwill

 

During any period in which the Company identifies an impairment trigger, the Company’s methodology includes internally generated separate cash flow projections for each reporting unit based on the different drivers that affect each reporting unit. The Company compares the fair values of each of its reporting units to their respective carrying amounts. If the carrying value of a reporting unit exceeds its estimated fair value, a goodwill impairment charge is recorded for the difference, with the impairment loss limited to the total amount of goodwill allocated to that reporting unit. The fair values of each of the Company’s reporting units were derived using the income approach, specifically the discounted cash flow method. The use of a discounted cash flow analysis requires significant judgment to estimate the future cash flows and the period of time over which those cash flows will be realized, as well as to determine the appropriate discount rate. The discounted cash flow model reflects management’s assumptions regarding revenue growth rates, risk-adjusted discount rates, terminal period growth rates, economic and market trends, and other expectations about the anticipated operating results of the Company’s reporting units. As part of the goodwill impairment test, the Company also considers its market capitalization in assessing the reasonableness of the combined fair values estimated for its reporting units. Substantial changes in the cash flows assumptions of the different reporting units may lead to a future impairment or may alter the implied distribution of value between the different reporting units. A material decline in the Company’s stock price may affect the imputed discount rate and the distribution of value between the reporting units, which may also lead to a future impairment.

 

The carrying value of goodwill, all of which was assigned to the Company’s BioBanking reporting unit, was $7,347 at both December 31, 2025 and 2024. At December 31, 2025, the Company performed a qualitative assessment to determine whether the existence of events or circumstances would indicate that it was more likely than not that the that the fair value of the reporting unit is less than its carrying amount. Based on the assessment, there was no goodwill impairment recognized during the year ended December 31, 2025. At December 31, 2024, the Company performed a qualitative assessment to determine whether the existence of events or circumstances would indicate that it was more likely than not that the that the fair value of the reporting unit is less than its carrying amount. Based on the assessment, there was no goodwill impairment recognized during the year ended December 31, 2024.

 

Reconciliations of the change in the carrying value of goodwill by segment for the years ended December 31, 2025 and 2024 are as follows:

   Balance at         Balance at 
   December 31, 2024  

Goodwill

Recognized

  

Goodwill

Impairment

   December 31, 2025 
                 
BioBanking  $7,347   $   $   $7,347 
Total  $7,347   $   $   $7,347 

 

   Balance at         Balance at 
   December 31, 2023  

Goodwill

Recognized

  

Goodwill

Impairment

   December 31, 2024 
                 
BioBanking  $7,347   $   $   $7,347 
Total  $7,347   $   $   $7,347 

 

 

Intangible Assets, Net

 

Intangible assets, net consisted of the following:

 

   December 31,   Estimated Useful
   2025   2024   Lives
Amortizable intangible assets:             
Developed technology  $16,810   $16,810   1116 years
Customer relationships   2,413    2,413   10 years
Trade names & trademarks   570    570   1013 years
Reacquired rights   4,200    4,200   6 years
    23,993    23,993    
Less: accumulated amortization             
Developed technology   (10,068)   (8,895)   
Customer relationships   (2,229)   (1,965)   
Trade names & trademarks   (440)   (385)   
Reacquired rights   (4,200)   (4,200)   
    (16,937)   (15,445)   
Amortizable intangible assets, net   7,056    8,548    
              
Non-amortized intangible assets             
Acquired IPR&D product rights   700    700   indefinite
   $7,756   $9,248    

 

Amortization expense for intangible assets was $1,492 and $1,753 for the years ended December 31, 2025 and 2024, respectively.

 

No impairment charges were recorded on intangible assets for the years ended December 31, 2025 and 2024.

 

Aggregate amortization expense for each of the five succeeding years and thereafter related to intangible assets held as of December 31, 2025 is estimated as follows:

 

      
2026  $1,356 
2027   1,258 
2028   1,208 
2029   1,155 
2030   1,155 
Thereafter   924 
Amortization expense  $7,056